Pharvaris PHVS
NASDAQ PHVS
$36.27 +0.61 (+1.71%)
As of: Sep 4, 2026 · 2:19 PM EDT

Pharvaris (PHVS) Interest & Investment Income (2021 - 2023)

Analysis

Pharvaris (PHVS) Interest & Investment Income (2021 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 138.92 Bn 131.07 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.55 Bn 58.37 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.26 Bn 53.13 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.08 Bn 44.08 Bn - 35.58 Mn
6 BeOne Medicines 39.98 Bn 34.89 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.32 Bn 32.01 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.42 Bn 27.59 Bn - 5.13 Mn
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn 10.98 Mn
10 Pharvaris 2.15 Bn 1.78 Bn 85,072.10 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -9.52 Mn
Dec 31, 2022 -15.64 Mn
Sep 30, 2022 11.59 Mn
Dec 31, 2021 4.44 Mn
Sep 30, 2021 5.02 Mn